Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
Simona Camorani(National Academies of Sciences, Engineering, and Medicine), Laura Cerchia(National Academies of Sciences, Engineering, and Medicine)
Cited by 23
Related Papers
Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
|Scientific Reports|2017|93
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
|Theranostics|2017|91
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
|Journal of Experimental & Clinical Cancer Research|2021|82
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2020|70